These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11790488)

  • 21. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
    Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding.
    Cugovčan M; Jablan J; Lovrić J; Cinčić D; Galić N; Jug M
    J Pharm Biomed Anal; 2017 Apr; 137():42-53. PubMed ID: 28092854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-assembly of cyclodextrin complexes: effect of temperature, agitation and media composition on aggregation.
    Messner M; Kurkov SV; Maraver Palazón M; Álvarez Fernández B; Brewster ME; Loftsson T
    Int J Pharm; 2011 Oct; 419(1-2):322-8. PubMed ID: 21839156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.
    Cavalli R; Peira E; Caputo O; Gasco MR
    Int J Pharm; 1999 May; 182(1):59-69. PubMed ID: 10332075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in membrane biophysical properties induced by the Budesonide/Hydroxypropyl-β-cyclodextrin complex.
    Dos Santos AG; Bayiha JC; Dufour G; Cataldo D; Evrard B; Silva LC; Deleu M; Mingeot-Leclercq MP
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1930-1940. PubMed ID: 28642042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
    Hegge AB; Másson M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A New Approach for Quantitative Determination of γ-Cyclodextrin in Aqueous Solutions: Application in Aggregate Determinations and Solubility in Hydrocortisone/γ-Cyclodextrin Inclusion Complex.
    Saokham P; Loftsson T
    J Pharm Sci; 2015 Nov; 104(11):3925-3933. PubMed ID: 26249751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of drug-cyclodextrin complexes by a phase-distribution method: some theoretical and practical considerations.
    Másson M; Sigurdardóttir BV; Matthíasson K; Loftsson T
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):958-64. PubMed ID: 16079528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics.
    Fülöp Z; Saokham P; Loftsson T
    Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.
    Tirucherai GS; Mitra AK
    AAPS PharmSciTech; 2003; 4(3):E45. PubMed ID: 14621977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDs as solubilizers: effects of excipients and competing drugs.
    Jansook P; Loftsson T
    Int J Pharm; 2009 Sep; 379(1):32-40. PubMed ID: 19524652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin.
    Manosroi J; Apriyani MG; Foe K; Manosroi A
    Int J Pharm; 2005 Apr; 293(1-2):235-40. PubMed ID: 15778061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous interaction of steroidal drugs with gamma- and hydroxypropyl-beta-cyclodextrin studied by charge-transfer chromatography.
    Cserháti T; Forgács E
    J Pharm Biomed Anal; 2000 Feb; 22(1):25-31. PubMed ID: 10727120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of aqueous diffusion layer on passive drug diffusion from aqueous cyclodextrin solutions through biological membranes.
    Loftsson T; Konrádsdóttir F; Másson M
    Pharmazie; 2006 Feb; 61(2):83-9. PubMed ID: 16526552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions.
    Loftsson T; Saokham P; Sá Couto AR
    Int J Pharm; 2019 Apr; 560():228-234. PubMed ID: 30771468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion complex formation of steroidal drugs with hydroxypropyl-beta-cyclodextrin studied by charge-transfer chromatography.
    Cserháti T; Forgács E
    J Pharm Biomed Anal; 1998 Oct; 18(1-2):179-85. PubMed ID: 9863956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of stability constant of beta-cyclodextrin complexes using the membrane permeation technique and the permeation behavior of drug-competing agent-beta-cyclodextrin ternary systems.
    Ono N; Hirayama F; Arima H; Uekama K
    Eur J Pharm Sci; 1999 May; 8(2):133-9. PubMed ID: 10210736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced stability of sulfamethoxazole and trimethoprim against oxidation using hydroxypropyl-beta-cyclodextrin.
    Pourmokhtar M; Jacobson GA
    Pharmazie; 2005 Nov; 60(11):837-9. PubMed ID: 16320945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.